BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18673232)

  • 1. Searching for differences between fibrinogen and fibrin that affect the initiation of fibrinolysis.
    Doolittle RF
    Cardiovasc Hematol Agents Med Chem; 2008 Jul; 6(3):181-9. PubMed ID: 18673232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen gamma chain functions.
    Mosesson MW
    J Thromb Haemost; 2003 Feb; 1(2):231-8. PubMed ID: 12871494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin structures during tissue-type plasminogen activator-mediated fibrinolysis studied by laser light scattering: relation to fibrin enhancement of plasminogen activation.
    Bauer R; Hansen SL; Jones G; Suenson E; Thorsen S; Ogendal L
    Eur Biophys J; 1994; 23(4):239-52. PubMed ID: 7805626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen and fibrin.
    Weisel JW
    Adv Protein Chem; 2005; 70():247-99. PubMed ID: 15837518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of initiation of fibrinolysis by fibrin.
    Medved L; Nieuwenhuizen W
    Thromb Haemost; 2003 Mar; 89(3):409-19. PubMed ID: 12624622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of fibrinogen and fibrin in hemostasis and thrombosis.
    Mosesson MW
    Semin Hematol; 1992 Jul; 29(3):177-88. PubMed ID: 1641664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation by fibrinogen and fibrin of tissue plasminogen activator kinetics and inhibition by plasminogen activator inhibitor 1.
    Thelwell C; Longstaff C
    J Thromb Haemost; 2007 Apr; 5(4):804-11. PubMed ID: 17408411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W
    Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin self-assembly is adapted to oxidation.
    Rosenfeld MA; Bychkova AV; Shchegolikhin AN; Leonova VB; Kostanova EA; Biryukova MI; Sultimova NB; Konstantinova ML
    Free Radic Biol Med; 2016 Jun; 95():55-64. PubMed ID: 26969792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conversion of fibrinogen to fibrin: mechanism of exposure of tPA- and plasminogen-binding sites.
    Yakovlev S; Makogonenko E; Kurochkina N; Nieuwenhuizen W; Ingham K; Medved L
    Biochemistry; 2000 Dec; 39(51):15730-41. PubMed ID: 11123898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure and biological features of fibrinogen and fibrin.
    Mosesson MW; Siebenlist KR; Meh DA
    Ann N Y Acad Sci; 2001; 936():11-30. PubMed ID: 11460466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the activation rates of plasminogen by tissue plasminogen activator and urokinase.
    Takada A; Shizume K; Cho M; Takada Y
    Thromb Res; 1987 Feb; 45(4):371-81. PubMed ID: 2437668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization in the fibrinogen gamma-chain of a new site that is involved in the acceleration of the tissue-type plasminogen activator-catalysed activation of plasminogen.
    Yonekawa O; Voskuilen M; Nieuwenhuizen W
    Biochem J; 1992 Apr; 283 ( Pt 1)(Pt 1):187-91. PubMed ID: 1567367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural studies of fibrinolysis by electron microscopy.
    Veklich Y; Francis CW; White J; Weisel JW
    Blood; 1998 Dec; 92(12):4721-9. PubMed ID: 9845538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin clot structure and mechanics associated with specific oxidation of methionine residues in fibrinogen.
    Weigandt KM; White N; Chung D; Ellingson E; Wang Y; Fu X; Pozzo DC
    Biophys J; 2012 Dec; 103(11):2399-407. PubMed ID: 23283239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI; Leslie B; Ginsberg J
    J Clin Invest; 1991 Mar; 87(3):1082-90. PubMed ID: 1900308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the beta-chain hole of fibrinogen with synthetic peptides that differ at their amino termini.
    Doolittle RF; Pandi L
    Biochemistry; 2007 Sep; 46(35):10033-8. PubMed ID: 17688324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in clinical fibrinolysis.
    Hessel LW; Kluft C
    Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.